Article Test

Home  >  Medical Research Archives  >  Issue 149  > Smoking Cessation Management for Lung Cancer Smokers: An Essential Component of Treatment
Published in the Medical Research Archives
Sep 2023 Issue

Smoking Cessation Management for Lung Cancer Smokers: An Essential Component of Treatment

Published on Sep 28, 2023

DOI 

Abstract

 

In 2020 lung cancer has been the leading cause of cancer death, with an estimated 1.8 million deaths; in other words of 18% of cancer deaths. Tobacco smoking is cause of 90% of lung cancers. Despite advances in lung cancer treatment, tobacco control is the most effective measure for curbing the lung cancer epidemic. Smoking cessation, at all stages of the cancer process, is associated with benefits in terms of cure, increased life expectancy and quality of life for patients, reduced medical and surgical complications, as well as it reduces risks of recurrence or of a second primary cancer. Smoking cessation medications combined with psychological support facilitate to quit smoking. Smoking cessation management is an essential component of lung cancer treatment. Researches into the best modalities to manage smoking cessation in lung cancer patients must be conducted. Nevertheless, healthcare professionals involved in the care of cancer patients must be trained to provide personalized assistance to help smokers stopping smoking.

Author info

Jean Perriot, Michel Underner, Gérard Peiffer

Have an article to submit?

Submission Guidelines

Submit a manuscript

Become a member

Call for papers

Have a manuscript to publish in the society's journal?